IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees
Sign Up to like & getrecommendations! Published in 2020 at "JCI Insight"
DOI: 10.1172/jci.insight.140925
Abstract: While the RV144 HIV vaccine trial led to moderately reduced risk of HIV acquisition, emerging data from the HVTN702 trial point to the critical need to reexamine RV144-based correlates of reduced risk of protection. While… read more here.
Keywords: igg1; iga; igg3; rv144 ... See more keywords